Cargando…
Active multiple myeloma suppresses and typically eliminates coexisting MGUS
BACKGROUND: Myeloma is consistently preceded by premalignant monoclonal gammopathy of undetermined significance (MGUS). In >5% of MGUS patients there is a second MGUS clone (biclonal gammopathy of undetermined significance; BGUS), yet, at myeloma diagnosis, presentation of biclonal gammopathy mye...
Autores principales: | Campbell, John P, Heaney, Jennifer L J, Pandya, Sankalp, Afzal, Zaheer, Kaiser, Martin, Owen, Roger, Child, J Anthony, Gregory, Walter, Morgan, Gareth J, Jackson, Graham H, Bunce, Chris M, Drayson, Mark T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589985/ https://www.ncbi.nlm.nih.gov/pubmed/28728165 http://dx.doi.org/10.1038/bjc.2017.229 |
Ejemplares similares
-
Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012) -
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
por: Heaney, Jennifer L. J., et al.
Publicado: (2018) -
The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
por: Giannopoulos, K, et al.
Publicado: (2012) -
Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling
por: Zismanov, V, et al.
Publicado: (2009) -
PDK1 inhibition is a novel therapeutic target in multiple myeloma
por: Fujiwara, S, et al.
Publicado: (2013)